Stocks and Investing Stocks and Investing
Wed, March 13, 2013
Tue, March 12, 2013

Delcath Systems Inc (NASDAQ:DCTH), Down By 16.84% ($0.33) From $1.960 After BUYINS.NET Report Predicted Weakness Before Earning


Published on 2013-03-12 07:45:54 - WOPRAI
  Print publication without navigation


March 12, 2013 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Monday, March 11th 2013 stating that Delcath Systems Inc (NASDAQ:DCTH) was expected to be Down Before its earnings release. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=dcth&id=353314

At the time this story was written, Delcath Systems Inc (NASDAQ:DCTH) is Down By 16.84% ($0.33) From $1.960 since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

Delcath Systems Inc (NASDAQ:DCTH) - Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company. It focuses on oncology, primarily cancers in the liver. The company engages in the development and clinical study of the Delcath chemosaturation system, which allows the administration of concentrated regional chemotherapy by isolating the circulatory system of the targeted organ. It delivers high doses of chemotherapeutic agents directly to the liver while limiting systemic exposure and the related side effects by filtering the blood prior to returning it to the patient. The company intends to sell its products directly to interventional radiologists and hospitals in the United States and internationally. It has a research and distribution agreement with Chi-Fu Trading Co., Ltd. to conduct clinical studies, as well as market, sell, and distribute the Delcath chemosaturation system in Taiwan and Singapore. The company was founded in 1988 and is headquartered in New York, New York..

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.

GATS -- tracks and quantifies known trading strategies.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. Delcath Systems Inc (NASDAQ:DCTH) has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net

Contributing Sources